Transcriptome profiling of human dermal MDPL fibroblasts reveals a characteristic molecular signature providing

Michela Murdocca1, Gerardo Pepe2, Serena Maccaroni1

  • 1Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.

Journal of Molecular Medicine (Berlin, Germany)
|October 14, 2025
PubMed

Insights

MDPL syndrome, a rare genetic disorder, involves DNA polymerase delta (Polδ) variants. Researchers identified molecular signatures in patient fibroblasts, revealing impaired DNA repair mechanisms crucial for genomic stability and potential therapeutic targets.

Area of Science:

  • Genetics and Molecular Biology
  • Cellular Biology
  • Dermatology

Background:

  • MDPL syndrome is a rare genetic disorder characterized by mandibular hypoplasia, deafness, progeroid features, and lipodystrophy.
  • Variants in the POLD1 gene, encoding DNA polymerase delta (Polδ), are associated with MDPL syndrome.
  • Polδ is essential for DNA replication and repair, making its dysfunction critical for genomic integrity.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying MDPL syndrome by analyzing gene expression in patient-derived fibroblasts.
  • To identify molecular signatures and functional deficits in human dermal fibroblasts (HDFs) from MDPL patients.
  • To explore the impact of DNA damage on MDPL HDFs and identify specific molecular alterations.

Main Methods:

  • RNA sequencing was performed on human dermal fibroblasts (HDFs) from two MDPL patients and compared to wild-type (WT) HDFs.
  • Bioinformatic analyses identified differentially expressed transcripts related to extracellular matrix and signal transduction.
  • X-irradiation was used to induce DNA damage, followed by transcriptomic analysis to assess repair capacity in MDPL HDFs.

Main Results:

  • Transcriptomic profiling revealed a distinct molecular signature in MDPL HDFs, including altered extracellular matrix and signal transduction markers.
  • Irradiated MDPL HDFs showed specific downregulated molecular traits involved in DNA replication and repair pathways.
  • Functional validation confirmed alterations in key proteins (CDC6, CLSPN, XRCC3, RAD51) essential for maintaining genomic stability.

Conclusions:

  • MDPL syndrome is associated with molecular deficits in DNA replication and repair mechanisms within dermal fibroblasts.
  • The identified molecular signature and functional impairments provide insights into MDPL pathogenesis.
  • These findings suggest potential therapeutic targets for MDPL syndrome and aging-related diseases.